Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interactions Between Cannabinoids and Cytochrome P450-Metabolized Drugs
NCT04201197Phase 1Completed
- Sponsor
- Johns Hopkins University
- Start
- Nov 2020
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial comparing Inje Cocktail (Placebo), Inje Cocktail + THC extract and Inje Cocktail + THC/CBD extract (3 arms). Primary endpoints: Losartan Area Under the Curve in Plasma at 24 hours, Peak Change From Baseline Number of Correct Trials on Paced Auditory Serial Addition Task at 8 hours and 4 more. Started Nov 2020; status: completed.
02
Drugs
dronabinolcannabidiol
Beyond the preview
Go deeper on NCT04201197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04201197.